Tag Archive | "Schizophrenia"

Alkermes: Partnering activity 2007-2014

Tags: , , ,


Alkermes, a fully integrated global biopharma company, is headquartered in Dublin, Ireland. It has emerged as a big biotech company applying the expertise to develop innovative medicines to improve patient outcomes. Its primary therapy focus areas are CNS disorders, such as schizophrenia, addiction and depression. Read the full story

Alkermes: Specialists in Schizophrenia

Tags: , ,


Alkermes is a Dublin based global biopharmaceutical company developing treatments for CNS disorders including schizophrenia, addiction and depression. Read the full story

Big pharma, Forest Lab grabs schizophrenia drugs from Merck

Tags: , , , ,


Forest Laboratories, big pharma, announced that is acquiring exclusive rights in the United States for Saphris (asenapine). Read the full story

Retrophin in $25 million private financing round

Tags: , , ,


Retrophin has entered into definitive agreements with a number of new and existing institutional investors in connection with a private financing placement, or PIPE. Read the full story

Schizophrenia Partnering

Tags: , ,


The Schizophrenia Partnering provides understanding and access to the schizophrenia partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story

cpbannerad300x150new2gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new1gif
rauconbadgejpg
e78banner300x150animgif